Individual Product Bioequivalence Recommendations for Specific Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 10, 2010
April 24, 2020
321fabfb-8008-4b1d-856f-9a2e7d5e26b1
Related Documents
End-of-Phase 2A Meetings
Guidance DocumentSeptember 18, 2009Center for Drug Evaluation and Research
Residual Solvents in Drug Products Marketed in the United States: Guidance for Industry
Guidance DocumentNovember 25, 2009Center for Drug Evaluation and Research
ANDAs: Impurities in Drug Products: Guidance for Industry
Guidance DocumentNovember 29, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.